Condition
Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07033481Phase 2RecruitingPrimary
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
NCT07219680Not ApplicableRecruiting
Intervention for Communication Quality of Life in Primary Progressive Aphasia
NCT04363684Recruiting
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
NCT02966145Completed
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
NCT02365922Completed
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Showing all 5 trials